PONTE VEDRA – – October 27, 2026 -- Cadrenal Therapeutics (Nasdaq: CVKD) has agreed to raise $3 million in gross proceeds from a single healthcare-focused institutional investor. Warrants could bring in about $5.8 million more if exercised in full for cash.

Airport City, Israel – September 18, 2026 -- MySize, Inc. (NASDAQ: MYSZ) has signed definitive agreements to sell 1,308,901 shares of common stock, or pre-funded warrants in lieu thereof, at $1.91 per share, generating expected gross proceeds of approximately $2.5 million.